Evidence map›Paper›PMID 11940267›Full record

ReviewCritical care (London, England)2002

Bench-to-bedside review: genetic influences on meningococcal disease.

Clementien L Vermont, Ronald de Groot, Jan A Hazelzet

Open access · goldAbstract readReview
In one paragraph

Review in Critical care (London, England), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Clementien L VermontSophia Children's Hospital, Rotterdam, The Netherlands.
Ronald de Groot
Jan A Hazelzet
Erasmus MC - Sophia Children’s Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review discusses the possible involvement of a variety of genetic polymorphisms on the course of meningococcal disease. It has been shown that several common genetic polymorphisms can either influence the susceptibility to meningococcal disease or can account for a higher mortality rate in patients. Gene polymorphisms concerning antibody receptors, lipopolysaccharide (LPS) binding receptors or proteins, innate complement proteins as well as cytokines and hemostatic proteins are described. The study of genetic polymorphisms might provide important insights in the pathogenesis of meningococcal disease and could make it possible to identify individuals who are at risk of either contracting or dying from meningococcal disease.

Indexed as

AdolescentAdultChild, PreschoolComplement System ProteinsGenetic Predisposition to DiseaseGenotypeHumansInterleukin-1Interleukin-6LectinsMeningococcal InfectionsMiddle AgedNeisseria meningitidisPhagocytosisPlasminogen Activator Inhibitor 1Polymorphism, GeneticComplement System ProteinsInterleukin-1Interleukin-6LectinsPlasminogen Activator Inhibitor 1Receptors, IgGTumor Necrosis Factor-alpha

Identifiers

PMID11940267
PMCPMC137398
OpenAlexW1489704036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.